← Back to Search

Staff for Caregiver

N/A

Waitlist Available

Led By Liu Wen, PhD

Research Sponsored by University of Iowa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up t1 (baseline), t2 (6-weeks post baseline), t3 (12-weeks post baseline)

Awards & highlights

Study Summary

This trialaims to develop & refine an intervention protocol & training materials to teach staff to better engage residents in eating. Through focus groups, pilot testing, and data collection, the team will assess its feasibility, fidelity, & usefulness.

Eligible Conditions

Caregiver of People With Alzheimer's Disease or Related Dementia (ADRD)

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ t1 (baseline), t2 (6-weeks post baseline), t3 (12-weeks post baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~t1 (baseline), t2 (6-weeks post baseline), t3 (12-weeks post baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and t1 (baseline), t2 (6-weeks post baseline), t3 (12-weeks post baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Staff Participants Who Viewed the Intervention Was Useful

Number of Staff Participants Who Viewed the Intervention as Appropriate and Acceptable for Mealtime Care Practice

Number of Staff and Resident Participants Recruited and Retained for the Study

+5 more

Secondary outcome measures

Quality of Staff Engagement

Resident Body Mass Index (BMI).

Trial Design

2Treatment groups

Experimental Treatment

Group I: StaffExperimental Treatment1 Intervention

Start participants who enrolled in the study, received the OPTIMAL intervention, and were observed during data collection.

Group II: ResidentExperimental Treatment1 Intervention

Resident participants who were cared in the study site, and received care from the staff participants before and after the OPTIMAL intervention was delivered to staff.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

OPTIMAL

2022

N/A

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH

1,669 Previous Clinical Trials

28,005,003 Total Patients Enrolled

University of IowaLead Sponsor

446 Previous Clinical Trials

879,391 Total Patients Enrolled

Liu Wen, PhDPrincipal InvestigatorThe University Of Iowa College Of Nursing

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for prospective participants in this experiment?

"The clinicaltrials.gov portal indicates that this medical experiment is currently enrolling patients. It was first introduced to the public on June 3rd 2022, and has been edited as recently as October 31st 2022."

Answered by AI

Is there an estimated count of participants who have signed up for the research?

"Affirmative. The clinicaltrials.gov database suggests that this medical trial is presently enrolling patients after being initial posted on June 3rd 2022 and most recently updated on October 31st 2022. Around 60 participants need to be recruited from a single site for the study's completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

OPTIMAL in NH Residents With Dementia

Wen Liu 2022. "OPTIMAL in NH Residents With Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05255068.